Bovine rota-coronavirus vaccine (killed virus) Clostridium perfringens type C - Escherichia coli bacterin-toxoid. Use for vaccination of healthy, pregnant cows and heifers as an aid in preventing diarrhea in their calves caused by bovine rotavirus (serotypes G6 and G10), bovine coronavirus, enterotoxigenic strains of E. coli having the K99 pili adherence factor and Clostridium perfringens type C.
General Directions: Vaccination of healthy, pregnant cows and heifers is recommended. Mix well. Aseptically administer 2 mL intramuscularly (IM) only. In accordance with Beef Quality Assurance guidelines, this product should be administered in the muscular region of the neck.
Primary Vaccination: Administer two IM doses approximately three weeks apart to pregnant cows, with the second dose given three to six weeks before calving.
Revaccination: Revaccination with a single dose three to six weeks before each subsequent calving is recommended. Good animal husbandry and herd-health management practices, including biosecurity, infectious disease control and annual revaccination should be employed.